Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective? An Analysis Using UK Based Electronic Health Records of 5.6 Million Individuals.

NCT04322786 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT04322786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04322786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective? An Analysis Using UK Based Electronic Health Records of 5.6 Million Individuals.
Lead sponsor
University College, London
Phase
Observational
Overall status
Unknown status
Start date
January 1, 1998
Completion date
March 31, 2021
Enrollment
1,302,508 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, coronavirus, angiotensin converting enzyme inhibitors, influenza, electronic health records, epidemiology, comorbidity, incidence, united kingdom